Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cagan Gurer

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Communications Biology|April 22, 2023
Spontaneous tumor regression mediated by human T cells in a humanized immune system mouse modelA K Patel, Ankur Dhanik, Wei Keat Lim, et al.
Oncoimmunology|September 14, 2020
Endogenous retroviral proteins provide an immunodominant but not requisite antigen in a murine immunotherapy tumor modelXuan Ye, Janelle C Waite, Ankur Dhanik, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Humanized mouse model supports development, function, and tissue residency of human natural killer cellsDietmar Herndler-Brandstetter, Liang Shan, Yi Yao, et al.
Science Immunology|November 4, 2018
<b>Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8</b>Bei Wang, Wen Zhang, Vladimir Jankovic, et al.
Nature|January 7, 2015
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutationsKai Deng, Mihaela Pertea, Anthony Rongvaux, et al.
Cell|July 8, 2022
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapyAdrienne M Luoma, Shengbao Suo, Yifan Wang, et al.
Cancer Immunology Research|July 27, 2022
Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054Richard Tavaré, Makenzie Danton, Jason T Giurleo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2019
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding propertiesLynn E Macdonald, Karoline A Meagher, Matthew C Franklin, et al.
Science Immunology|December 17, 2021
Humanization of T cell-mediated immunity in miceMichael J Moore, Maggie Zhong, Johanna Hansen, et al.
Science Translational Medicine|June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapyJanelle C Waite, Bei Wang, Lauric Haber, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Communications Biology|April 22, 2023
Spontaneous tumor regression mediated by human T cells in a humanized immune system mouse modelA K Patel, Ankur Dhanik, Wei Keat Lim, et al.
Oncoimmunology|September 14, 2020
Endogenous retroviral proteins provide an immunodominant but not requisite antigen in a murine immunotherapy tumor modelXuan Ye, Janelle C Waite, Ankur Dhanik, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Humanized mouse model supports development, function, and tissue residency of human natural killer cellsDietmar Herndler-Brandstetter, Liang Shan, Yi Yao, et al.
Science Immunology|November 4, 2018
<b>Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8</b>Bei Wang, Wen Zhang, Vladimir Jankovic, et al.
Nature|January 7, 2015
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutationsKai Deng, Mihaela Pertea, Anthony Rongvaux, et al.
Cell|July 8, 2022
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapyAdrienne M Luoma, Shengbao Suo, Yifan Wang, et al.
Cancer Immunology Research|July 27, 2022
Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054Richard Tavaré, Makenzie Danton, Jason T Giurleo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2019
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding propertiesLynn E Macdonald, Karoline A Meagher, Matthew C Franklin, et al.
Science Immunology|December 17, 2021
Humanization of T cell-mediated immunity in miceMichael J Moore, Maggie Zhong, Johanna Hansen, et al.
Science Translational Medicine|June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapyJanelle C Waite, Bei Wang, Lauric Haber, et al.
Pageof 3